PAR PHARM INC FDA Approval ANDA 207200

ANDA 207200

PAR PHARM INC

FDA Drug Application

Application #207200

Documents

Letter2019-06-17

Application Sponsors

ANDA 207200PAR PHARM INC

Marketing Status

Discontinued001

Application Products

001TABLET;ORAL100MG0SAPROPTERIN DIHYDROCHLORIDESAPROPTERIN DIHYDROCHLORIDE

FDA Submissions

UNKNOWN; ORIG1AP2019-05-10STANDARD
LABELING; LabelingSUPPL2AP2020-09-09STANDARD

Submissions Property Types

ORIG1Null15
SUPPL2Null7

TE Codes

001PrescriptionAB

CDER Filings

PAR PHARM INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 207200
            [companyName] => PAR PHARM INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"SAPROPTERIN DIHYDROCHLORIDE","activeIngredients":"SAPROPTERIN DIHYDROCHLORIDE","strength":"100MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"05\/10\/2019","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2019\\\/207200Orig1s000ltr.pdf\"}]","notes":"> Label is not available on this site."}]
            [supplements] => [{"actionDate":"09\/09\/2020","submission":"SUPPL-2","supplementCategories":"Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."}]
            [actionDate] => 2020-09-09
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.